Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma
Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma
Active, not recruiting · NCT05849610 · Registry updated 2026-05-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma | High-Risk de Novo Multiple Myeloma | Active, not recruiting | Phase 2 | 2026-05-11 | NCT05849610 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Janssen Pharmaceutica N.V., Belgium | 13 |
| PETHEMA Foundation | 21 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Clinica Universidad De Navarra | Pamplona | Spain | 20 |
| Complejo Hospitalario Santiago (CHUS) | Santiago de Compostela | Spain | 3 |
| H. Universitario Marqués de Valdecilla | Santander | Spain | 4 |
| Hospital Clinic i Provincial de Barcelona | Barcelona | Spain | 9 |
| Hospital Doce de Octubre | Madrid | Spain | 2 |
| Hospital Germans Trials i Pujol | Badalona | Spain | 2 |
| Hospital Universitari i Politecnic La Fe | Valencia | Spain | 14 |
| Hospital Universitario de Salamanca | Salamanca | Spain | 29 |
| Hospital Virgen de la Arrixaca | Murcia | Spain | 9 |
| Hospital Vírgen del Rocío | Seville | Spain | 2 |